Martin Morad to CRISPR-Cas Systems
This is a "connection" page, showing publications Martin Morad has written about CRISPR-Cas Systems.
Connection Strength
0.810
-
CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling. Cell Calcium. 2018 07; 73:104-111.
Score: 0.612
-
CRISPR/Cas9 Gene Editing of RYR2 in Human iPSC-Derived Cardiomyocytes to Probe Ca2+ Signaling Aberrancies of CPVT Arrhythmogenesis. Methods Mol Biol. 2022; 2573:41-52.
Score: 0.197